TLRYTilray, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · tilray.com

4.840USDMkt Cap: 665.89M $P/E: —3d ago

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, a…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap665.89M $

Enterprise Value2.01B $

Revenue (TTM)915.45M $

Gross Profit260.44M $

Net Income (TTM)-121.40M $

Revenue/Share8.186 USD

Last Price4.840 USD

Fiscal Year EndMay 2026

MR QuarterMar 2021

Employees3.6K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINUS88688T1007

Valuation

P/E (Trailing)—

P/E (Forward)10.38

PEG—

EV/EBITDA134.08

EV/Revenue2.20

P/S0.70

P/B1.55

EPS (TTM)-1.09

EPS (Forward)0.45

52W Range

4.71057% of range4.939

52W High4.939 USD

52W Low4.710 USD

Profitability

Gross Margin28.45%

Oper. Margin-52.70%

EBITDA Margin1.64%

Profit Margin-13.26%

ROE-7.52%

ROA-5.21%

Growth

Revenue Growth-7.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-69.14M $

CapEx (TTM)32.99M $

FCF Margin-2.73%

FCF Yield-3.76%

Net Debt-81.76M $

Net Debt/EBITDA-5.45

Balance Sheet

Debt/Equity0.25

Current Ratio2.21

Quick Ratio1.17

Book Value/Sh3.018 USD

Cash/Share0.9510 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateDec 2, 2025

Analyst Consensus

Rating—

Target (Mean)7.844 USD

Upside (mean)+62.1%

Target Range4.250 USD – 19.00 USD

$4.250+62.1% to mean$19.00

# Analysts8

Ownership

Shares Out.137.58M

Float439.97M

Insiders1.09%

Institutions10.89%

Short Interest

Short Ratio4.6d

Short % Float15.41%

Short % Out.15.31%

Shares Short20.85M

Short (prev mo.)17.80M

Technical

SMA 504.510 (+7.3%)

SMA 2007.089 (-31.7%)

Beta1.92

S&P 52W Chg21.00%

Avg Vol (30d)4.25M

Avg Vol (10d)3.75M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—